Sanbe Hest 200 Infusion Kenya - engelsk - Pharmacy and Poisons Board

sanbe hest 200 infusion

pt sanbe farma jl. taman sari no. 10 bandung west java,indonesia - hydroxyethyl starch 200 infusion - infusion - hydroxyethyl starch/hest 30 g (molar substitution… - hydroxyethylstarch

VOLUVEN 6% hydroxyethyl starch 130/0.4 500 mL solution for intravenous infusion bag Australia - engelsk - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 500 ml solution for intravenous infusion bag

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 250 mL solution for intravenous infusion bag Australia - engelsk - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 250 ml solution for intravenous infusion bag

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 500 mL solution for intravenous infusion bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 500 ml solution for intravenous infusion bottle

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

VOLUVEN 6% hydroxyethyl starch 130/0.4 250 mL solution for intravenous infusion bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

voluven 6% hydroxyethyl starch 130/0.4 250 ml solution for intravenous infusion bottle

fresenius kabi australia pty ltd - hydroxyethyl starch 130/0.4, quantity: 60 g/l - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.

PENTASTARCH 6 %, solution pour perfusion Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

pentastarch 6 %, solution pour perfusion

baxter sas - hydroxyéthylamidon 200 000 - solution - 60 g - composition pour 1000 ml de solution > hydroxyéthylamidon 200 000 : 60 g > chlorure de sodium : 9 g - substituts du plasma et fractions proteiques plasmatiques/amidons

VOLUVEN 6%+0,9% (W/V) ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

voluven 6%+0,9% (w/v) διαλυμα για εγχυση

fresenius kabi hellas ae (0000003822) Λεωφ. Μεσογείων 354, 153 41, Αγ. Παρασκευή, 153 41 - hydroxyethyl starch; sodium chloride - ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ - 6%+0,9% (w/v) - ineof01242 hydroxyethyl starch 60.000000 g; 0007647145 sodium chloride 9.000000 g - hydroxyethylstarch

VOLULYTE 6% W/V ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

volulyte 6% w/v διαλυμα για εγχυση

fresenius kabi hellas ae (0000003822) Λεωφ. Μεσογείων 354, 153 41, Αγ. Παρασκευή, 153 41 - poly-(0-2 hydroxyethyl)-starch (m.w 200000); sodium acetate trihydrate; sodium chloride; potassium chloride; magnesium chloride hexahydrate - ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ - 6% w/v - ineof00405 poly-(0-2 hydroxyethyl)-starch (m.w 200000) 60.000000 g; 0006131904 sodium acetate trihydrate 4.630000 g; 0007647145 sodium chloride 6.020000 g; 0007447407 potassium chloride 0.300000 g; 0007791186 magnesium chloride hexahydrate 0.300000 g - hydroxyethylstarch

HESTAR-200 Injection Kenya - engelsk - Pharmacy and Poisons Board

hestar-200 injection

claris otsuka private limited plot no : dmcc-ph2-j&gplexs - hydroxyethyl starch (200/0.5) - injection - 6 % w/v - blood substitutes and plasma protein fractions

Voluven New Zealand - engelsk - Medsafe (Medicines Safety Authority)

voluven

fresenius kabi new zealand limited - hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons); sodium chloride 0.9%; hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) - solution for infusion - active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) sodium chloride 0.9% excipient: hydrochloric acid sodium hydroxide water for injection active: hydroxyethyl starch 130/0.4 6% (molar substitution 0.38-0.45, av. mwt. 130,000 daltons) excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - treatment of hypovolaemia due to acute blood loss when chrystlloids alone are not considered sufficient. the use of voluven is not a substitute for the appropriate use of packed red blood cells or fresh frozen plasma.